Logo image of BLBD

BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

USA - NASDAQ:BLBD - US0953061068 - Common Stock

57.96 USD
-0.3 (-0.51%)
Last: 9/12/2025, 8:00:01 PM
57.96 USD
0 (0%)
After Hours: 9/12/2025, 8:00:01 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BLBD. BLBD was compared to 128 industry peers in the Machinery industry. BLBD has only an average score on both its financial health and profitability. BLBD may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make BLBD suitable for value investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BLBD had positive earnings in the past year.
BLBD had a positive operating cash flow in the past year.
In multiple years BLBD reported negative net income over the last 5 years.
In multiple years BLBD reported negative operating cash flow during the last 5 years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

BLBD has a better Return On Assets (20.14%) than 98.44% of its industry peers.
BLBD's Return On Equity of 52.24% is amongst the best of the industry. BLBD outperforms 98.44% of its industry peers.
The Return On Invested Capital of BLBD (28.56%) is better than 99.22% of its industry peers.
Industry RankSector Rank
ROA 20.14%
ROE 52.24%
ROIC 28.56%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

With a decent Profit Margin value of 8.16%, BLBD is doing good in the industry, outperforming 64.06% of the companies in the same industry.
In the last couple of years the Profit Margin of BLBD has grown nicely.
BLBD has a Operating Margin (10.02%) which is in line with its industry peers.
BLBD's Operating Margin has improved in the last couple of years.
The Gross Margin of BLBD (19.47%) is worse than 73.44% of its industry peers.
BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.02%
PM (TTM) 8.16%
GM 19.47%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

6

2. Health

2.1 Basic Checks

BLBD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
BLBD has more shares outstanding than it did 1 year ago.
BLBD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BLBD has an improved debt to assets ratio.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

BLBD has an Altman-Z score of 6.82. This indicates that BLBD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BLBD (6.82) is better than 87.50% of its industry peers.
The Debt to FCF ratio of BLBD is 0.64, which is an excellent value as it means it would take BLBD, only 0.64 years of fcf income to pay off all of its debts.
BLBD has a better Debt to FCF ratio (0.64) than 89.06% of its industry peers.
BLBD has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.39, BLBD is in line with its industry, outperforming 57.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.64
Altman-Z 6.82
ROIC/WACC2.87
WACC9.94%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

BLBD has a Current Ratio of 1.58. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
BLBD has a Current ratio of 1.58. This is in the lower half of the industry: BLBD underperforms 71.09% of its industry peers.
A Quick Ratio of 0.92 indicates that BLBD may have some problems paying its short term obligations.
BLBD has a Quick ratio of 0.92. This is in the lower half of the industry: BLBD underperforms 69.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.92
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

BLBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.95%, which is quite good.
Measured over the past years, BLBD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.38% on average per year.
BLBD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.31%.
The Revenue has been growing slightly by 5.74% on average over the past years.
EPS 1Y (TTM)13.95%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%30.77%
Revenue 1Y (TTM)9.31%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%19.39%

3.2 Future

BLBD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.19% yearly.
Based on estimates for the next years, BLBD will show a small growth in Revenue. The Revenue will grow by 4.99% on average per year.
EPS Next Y19.15%
EPS Next 2Y11.39%
EPS Next 3Y11.19%
EPS Next 5YN/A
Revenue Next Year9.39%
Revenue Next 2Y7.03%
Revenue Next 3Y8.89%
Revenue Next 5Y4.99%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.09, BLBD is valued correctly.
BLBD's Price/Earnings ratio is rather cheap when compared to the industry. BLBD is cheaper than 83.59% of the companies in the same industry.
BLBD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
Based on the Price/Forward Earnings ratio of 13.42, the valuation of BLBD can be described as correct.
BLBD's Price/Forward Earnings ratio is rather cheap when compared to the industry. BLBD is cheaper than 85.16% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BLBD to the average of the S&P500 Index (22.73), we can say BLBD is valued slightly cheaper.
Industry RankSector Rank
PE 15.09
Fwd PE 13.42
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BLBD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BLBD is cheaper than 75.00% of the companies in the same industry.
BLBD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BLBD is cheaper than 88.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.84
EV/EBITDA 11.18
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BLBD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.79
PEG (5Y)0.92
EPS Next 2Y11.39%
EPS Next 3Y11.19%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BLBD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUE BIRD CORP

NASDAQ:BLBD (9/12/2025, 8:00:01 PM)

After market: 57.96 0 (0%)

57.96

-0.3 (-0.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-24 2025-11-24/amc
Inst Owners119.23%
Inst Owner Change-5.43%
Ins Owners0.55%
Ins Owner Change-4.52%
Market Cap1.84B
Analysts83.08
Price Target57.7 (-0.45%)
Short Float %16.04%
Short Ratio8.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.14%
Min EPS beat(2)-0.8%
Max EPS beat(2)21.07%
EPS beat(4)3
Avg EPS beat(4)11.51%
Min EPS beat(4)-0.8%
Max EPS beat(4)21.07%
EPS beat(8)7
Avg EPS beat(8)46.57%
EPS beat(12)10
Avg EPS beat(12)-86.96%
EPS beat(16)11
Avg EPS beat(16)-81.93%
Revenue beat(2)1
Avg Revenue beat(2)1.19%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)3.33%
Revenue beat(4)2
Avg Revenue beat(4)1.51%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)4.34%
Revenue beat(12)9
Avg Revenue beat(12)6.43%
Revenue beat(16)11
Avg Revenue beat(16)6.25%
PT rev (1m)9.7%
PT rev (3m)9.7%
EPS NQ rev (1m)7.57%
EPS NQ rev (3m)-5.09%
EPS NY rev (1m)6.96%
EPS NY rev (3m)6.96%
Revenue NQ rev (1m)-4.06%
Revenue NQ rev (3m)-4.21%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 15.09
Fwd PE 13.42
P/S 1.29
P/FCF 12.84
P/OCF 11.04
P/B 8.28
P/tB 11.42
EV/EBITDA 11.18
EPS(TTM)3.84
EY6.63%
EPS(NY)4.32
Fwd EY7.45%
FCF(TTM)4.51
FCFY7.79%
OCF(TTM)5.25
OCFY9.06%
SpS44.81
BVpS7
TBVpS5.07
PEG (NY)0.79
PEG (5Y)0.92
Profitability
Industry RankSector Rank
ROA 20.14%
ROE 52.24%
ROCE 41.05%
ROIC 28.56%
ROICexc 56.99%
ROICexgc 87.8%
OM 10.02%
PM (TTM) 8.16%
GM 19.47%
FCFM 10.07%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y220.13%
ROICexcg growth 5Y10.5%
ROICexc growth 3Y207.87%
ROICexc growth 5Y19.73%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
F-Score7
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.64
Debt/EBITDA 0.55
Cap/Depr 149.83%
Cap/Sales 1.64%
Interest Coverage 13.04
Cash Conversion 105.36%
Profit Quality 123.49%
Current Ratio 1.58
Quick Ratio 0.92
Altman-Z 6.82
F-Score7
WACC9.94%
ROIC/WACC2.87
Cap/Depr(3y)67.41%
Cap/Depr(5y)84.95%
Cap/Sales(3y)0.9%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.95%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%30.77%
EPS Next Y19.15%
EPS Next 2Y11.39%
EPS Next 3Y11.19%
EPS Next 5YN/A
Revenue 1Y (TTM)9.31%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%19.39%
Revenue Next Year9.39%
Revenue Next 2Y7.03%
Revenue Next 3Y8.89%
Revenue Next 5Y4.99%
EBIT growth 1Y-0.36%
EBIT growth 3Y177.79%
EBIT growth 5Y26.04%
EBIT Next Year39.1%
EBIT Next 3Y15.17%
EBIT Next 5Y13.76%
FCF growth 1Y34.94%
FCF growth 3YN/A
FCF growth 5Y36.54%
OCF growth 1Y45.83%
OCF growth 3YN/A
OCF growth 5Y14.81%